Full-Time

Director – Device Product Stewardship

Posted on 4/2/2025

Merck

Merck

10,001+ employees

Develops medicines and vaccines for health issues

Compensation Overview

$153.8k - $242.2k/yr

+ Bonus + Long Term Incentive

Expert

No H1B Sponsorship

North Wales, PA, USA + 1 more

More locations: Linden, NJ, USA

Hybrid work model consisting of three total days on-site per week, Monday - Thursday, with Friday designated as a remote-working day.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Risk Management
Requirements
  • Bachelor's degree in engineering, life sciences, or related field
  • 10+ years of experience in medical device engineering, combination product development, or related technical fields
  • Demonstrated experience in a leadership role, managing technical product stewardship, supply, or related functions
  • Strong understanding of medical device and combination product development and support from early stage through launch and supply, including mechanical systems design and manufacture, medical device design controls and device risk management, human factors evaluations, and design verification/validation
  • In-depth knowledge of global regulatory requirements for medical devices and combination products
  • Strong understanding of risk management principles, including ISO 14971 and other relevant standards
  • Excellent communication and interpersonal skills, with the ability to effectively engage with internal and external stakeholders
  • Proven track record of driving continuous improvement and implementing best practices in technical support and product stewardship
  • Strong strategic and analytical thinking, with a focus on driving continuous improvement and implementing best practices in technical support and product stewardship
Responsibilities
  • Provide strategic leadership and direction for technical support and product stewardship across assigned products, including managing ongoing changes to medical device and combination product designs and manufacturing processes
  • Collaborate with cross-functional teams to ensure that all products meet safety, efficacy, and quality, and robust supply standards throughout their lifecycle
  • Lead, mentor, and develop a team of technical staff, providing guidance on industry best practices and fostering a culture of continuous improvement
  • Oversee lifecycle changes for products, ensuring internal quality and technical requirements are achieved, and ensure filings with regulatory bodies to ensure compliance with relevant regulations and standards, including FDA, EU MDR, ISO, and other applicable guidelines
  • Drive proactive risk management activities, including risk assessment, risk mitigation, and risk communication strategies
  • Develop and maintain strong relationships with internal stakeholders, including R&D, quality, packaging, analytical, regulatory, manufacturing, Technical Product Leaders and Value Chain to facilitate effective technical support and product stewardship
  • Develop and maintain key performance indicators (KPIs) to measure and improve the effectiveness of technical product stewardship activities
Desired Qualifications
  • Advanced degree (Masters or PhD) preferred
  • Professional certifications (e.g., RAPS, ASQ, Six Sigma) and familiarity with statistical process control and improvement are highly desirable

Merck develops medicines and vaccines to address significant health challenges such as cardiovascular disease, diabetes, and cancer. The company conducts extensive research and development to create new treatments, focusing on the pharmaceutical and biotechnology sectors. Merck generates revenue through the sale of prescription medications, vaccines, and animal health products. A key aspect of Merck's approach is its commitment to patient assistance programs, which provide free medicines and vaccines to eligible patients. Additionally, Merck supports healthcare professionals with resources like Merck Connect and Merck Manuals, distinguishing itself from competitors by its comprehensive support for both patients and healthcare providers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kenilworth, Illinois

Founded

1891

Simplify Jobs

Simplify's Take

What believers are saying

  • Positive Phase 3 results for pembrolizumab suggest new cancer treatment opportunities.
  • Kinase inhibitors' use in autoimmune diseases offers Merck portfolio diversification.
  • Merck's digital health innovation leadership strengthens its competitive position.

What critics are saying

  • Data privacy concerns may arise from AI integration in healthcare settings.
  • Oral peptide delivery faces scientific and regulatory challenges.
  • Intensifying competition from companies like Novartis may impact Merck's market share.

What makes Merck unique

  • Merck's collaboration with Microsoft enhances clinical workflows using AI in healthcare.
  • The Cyprumed deal aims to make peptide drugs orally available, improving patient experience.
  • Merck's investment in vaccine manufacturing aligns with rising global vaccine demand.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Holidays

Paid Vacation

Paid Sick Leave

Hybrid Work Options

Flexible Work Hours

Company News

Healthcare Dive
Apr 16th, 2025
Merck Manuals Integrates Medical Reference Within Microsoft Copilot Studio

This collaboration exemplifies a commitment to enhancing clinical workflows by incorporating Merck Manuals' authoritative content into Microsoft's healthcare agent service in Copilot Studio.

Sandra Gona
Apr 16th, 2025
India logs 2,430 new Covid cases_Spider information

As a result of these efforts, Merck has been recognized as a "Digital Health Innovation Leader" for two consecutive years since 2023.

BioSpace
Apr 15th, 2025
Merck Eyes Oral Peptide Delivery With Cyprumed Deal Worth up to $493M

Merck on Tuesday entered into a nonexclusive licensing and option pact with Austrian biotech Cyprumed in a bid to make its peptide drugs orally available.

PR Newswire
Apr 14th, 2025
Merck Manuals To Collaborate With Microsoft To Integrate Medical Information Resources Into Healthcare Agent Service In Microsoft Copilot Studio

RAHWAY, N.J., April 14, 2025 /PRNewswire/ -- The Merck Manuals is pleased to announce its collaboration with Microsoft to integrate its esteemed professional medical reference into healthcare agent service in Microsoft Copilot Studio. This exciting initiative harnesses the power of Generative AI (GenAI) to provide clinicians with trusted, comprehensive, and evidence-based medical content at the point of care.The Merck Manuals is proud to be an independent (non-government) medical information resource integrated into this platform. This collaboration exemplifies a commitment to enhancing clinical workflows by incorporating Merck Manuals' authoritative content into Microsoft's healthcare agent service in Copilot Studio. This integration empowers healthcare technology developers to create generative AI-driven healthcare agents that leverage this high-value content to grant clinicians immediate access to vital medical information."Clinicians and healthcare organizations worldwide depend on the Merck Manuals and MSD Manuals for accurate and reliable answers to their clinical questions," stated Dr. Sandy Falk, Editor-in-Chief of the Merck Manuals. "Through this collaboration with Microsoft, we are building solutions to deliver our comprehensive, evidence-based content to meet the needs of healthcare professionals

APP
Apr 14th, 2025
Novartis plans $23B expansion of manufacturing in US, including North Jersey site

Merck announced plans to spend $1 billion on a vaccine manufacturing site in North Carolina, plus $8 billion on other upgrades.

INACTIVE